J Korean Acad Psychiatr Ment Health Nurs.  2017 Dec;26(4):391-401. 10.12934/jkpmhn.2017.26.4.391.

The Effects of Group Motivational Interviewing Compliance Therapy on Drug Attitude, Medicine Application Self-efficacy and Medicine Application in Psychiatric Patients

• Lee D
• Kim S

• KMID: 2401226
• DOI: http://doi.org/10.12934/jkpmhn.2017.26.4.391

Abstract

PURPOSE
This study aims to verify the effects of the Group Motivational Interviewing Compliance Therapy on drug attitude, medicine application self-efficacy and medicine application in psychiatric patients.
METHODS
This was a quasi-experimental study with a non-equivalent control group pre-posttest design. Participants were 43 patients (22 in experimental group and 21 in control group) who were registered at neuro-psychiatric day care center in one university hospital, S city. The experimental group received the Group Motivational Interviewing Compliance Therapy for 6 sessions over 6 weeks. Data were collected between November, 2014 and September, 2016. Comparison of the pre-post results was performed by paired t-test and between-group effect was analyzed by ANCOVA with the SPSS/WIN 23.0 program.
RESULTS
The experimental group had a significant increase in drug attitude compared to the control group. However, there was no significant difference in medicine application self-efficacy and medicine application between the two groups.
CONCLUSION
The Group Motivational Interviewing Compliance Therapy is suggested as a promising program that helps psychiatric patients improve drug attitude. Further studies are needed to confirm the effects of the Group Motivational Interviewing Compliance Therapy.

Keyword

Motivational interviewing; Mesh; Drug attitude; Self-efficacy; Medication adherence

MeSH Terms

Compliance*
Day Care, Medical
Humans
Medication Adherence
Motivational Interviewing*
Non-Randomized Controlled Trials as Topic

Reference

1. You JH, Woo YS, Hahn C, Choi JW, Ko HJ. Predicting factors associated with drug compliance in psychiatric outpatients of a university hospital. The Korean Journal of Psychopharmacology. 2010; 21:29–34.

2. Kim JE, Moon JJ, Kim MH, Kim WJ, Park MK, Song TH, et al. Effects of psychoeducation program on insight and treatment attitudes in patients with schizophrenia, schizophreniform disorder, and schizoaffective disorder. The Korean Journal of Psychopharmacology. 2010; 21:87–94.

3. Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. Journal of psychiatric practice. 2009; 15(1):34–44. https://doi.org/10.1097/01.pra.0000344917.43780.77.

4. Kampman O, Lehtinen K. Compliance in psychoses. Acta psychiatrica Scandinavica. 1999; 100(3):167–175. https://doi.org/10.1111/j.1600-0447.1999.tb10842.x.

5. Lee PS. A study on nurses' and patients' perceptions of psychotropic medication. Journal of Nurses Academic Society. 1994; 24(1):47–57.

6. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month followup. The British Journal of Psychiatry. 1998; 172(5):413–419. https://doi.org/10.1192/bjp.172.5.413.

7. Mutsatsa SH, Joyce EM, Hutton SB, Webb E, Gibbins H, Paul S, et al. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica. 2003; 108(6):439–446. https://doi.org/10.1046/j.0001-690X.2003.00193.x.

8. Beebe LH, Smith K, Phillips C. Descriptions and correlates of medication adherence, attitudes, and self-efficacy in outpatients with schizophrenia spectrum disorders (SSDs). Archives of Psychiatric Nursing. 2016; 30(3):400–405. https://doi.org/10.1016/j.apnu.2016.01.010.

9. Marland GR. Atypical neuroleptics: autonomy and compliance? Journal of Advanced Nursing. 1999; 29(3):615–622. https://doi.org/10.1046/j.1365-2648.1999.00930.x.

10. Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–a review of the past decade. European psychiatry. 2012; 27(1):9–18. https://doi.org/10.1016/j.eurpsy.2011.02.005.

11. Gray R, Wykes T, Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing. 2002; 9(3):277–284.

12. Lee J, Bae J, Im S. Review of nursing research on psychotropic drugs in Korea. Journal of Korean Public Health Nursing. 2013; 27(2):338–356. https://doi.org/10.5932/JKPHN2013.27.2.338.

13. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed.New York: Guilford Press;2002. p. 425.

14. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal. 1996; 312(7027):345–349. https://doi.org/10.1136/bmj.312.7027.345.

15. Omranifard V, Karahmadi M, Jannesary Z, Maracy M. Efficacy of modified compliance therapy for schizophrenia patients. Journal of Research in Medical Sciences. 2012; Special Issue. (2):258–263. https://doi.org/10.1016/S0924-9338(13)76898-6.

16. Tay SEC. Compliance therapy: an intervention to improve inpatients' attitudes toward treatment. Journal of Psychosocial Nursing and Mental Health Services. 2007; 45(6):29–37.

17. Teesson M, Sannibale C, Reid S, Proudfoot H, Gournay K, Haber P. Manual for compliance therapy in alcohol pharmacotherapy. Technical Report. Sydney: National Drug and Alcohol Research Centre;2003. Report No.157.

18. Joung J, Kim S. Effects of a relapse prevention program on insight, empowerment and treatment adherence in patients with schizophrenia. Journal of Korean Academy of Nursing. 2017; 47(2):188–198. https://doi.org/10.4040/jkan.2017.47.2.188.

19. Yoon BH, Bahk WM, Lee KU, Hong CH, Ahn JK, Kim MK. Psychometric properties of Korean Version of Drug Attitude Inventory (KDAI-10). Korean Journal of Psychopharmacology. 2005; 16(6):480–487.

20. Lee HJ. Factors affecting medication compliance of hypertensive patients [master's thesis]. [Seoul]: Dankook University;2002. p. 79.

21. Hwang MS. Effects of the medication education on medication knowledge and medication compliance with schizophrenia [master's thesis]. [Seoul]: Yonsei University;1998. p. 51.

22. Shin GS. Effect of home visit education on the drug compliance for chronic schizophrenics in house and the caregiver's role [master's thesis]. [Chuncheon]: Kangwon National University;2001. p. 100.

23. Kim SY. A review on the statistical method for quasi-experimental data of nonequivalence control group design in nursing research. Journal of the Korean Data Analysis Society. 2005; 7(1):113–124.

24. Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophrenia Bulletin. 2013; 39(6):1242–1251. https://doi.org/10.1093/schbul/sbt138.

25. Wagner CC, Ingersoll KS. Motivational Interviewing in Groups. New York: Guilford Press;2012. p. 416.

26. Cha BK, Chang HK, Sohn JN. A metaanalysis of the effects of a self-efficacy promoting program. Journal of Korean Academy of Nursing. 2004; 34(6):934–944.

27. Song HR. Relationship among attitude toward drug, medication adherence, and internalized stigma of psychiatric outpatients [master's thesis]. [Seoul]: Kyung Hee University;2012. p. 74.

28. Seo M, Kim HR. Effectiveness of an 'integrated medication adherence enhancement program for persons with schizophrenia' by using online education contents. The Korean Journal of Psychopharmacology. 2009; 20(1):22–31.

29. Kwon JS, Shin SW, Cheong YM, Park KH. Medication compliance in psychiatric outpatients of a university hospital. Journal of Korean Neuropsychiatry Association. 1997; 36(3):523–529.